Toggle Main Menu Toggle Search

ePrints

Browsing publications by Christopher Fox

Newcastle AuthorsTitleYearFull text
Dr Amy Fearn
Dr Aldi Situmorang
Christopher Fox
Professor Fiona Oakley
Rachel Howarth
et al.		The NF-kB1 is a key regulator of acute but not chronic renal injury2017
Christopher Fox
Dr Pasquale Cocchiaro
Professor Fiona Oakley
Rachel Howarth
Krystena Callaghan
et al.		Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease2016
Dr Mujdat Zeybel
Dr Timothy Hardy
Stuart Robinson
Christopher Fox
Professor Quentin Anstee
et al.		Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease2015
Christopher Fox
Rachel Howarth
Krystena Callaghan
Dr Katrina Wood
Professor Fiona Oakley
et al.		Pepstatin A improves renal fibrosis by impairing UPA lysosomal recycling2015
Dr Caroline Wilson
Dr Lindsay Murphy
Jack Leslie
Dr Stuart Kendrick
Jeremy French
et al.		Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease2015
Dr Anna Moles Fernandez
Dr Lindsay Murphy
Dr Caroline Wilson
Dr Jayshree Bagchi Chakraborty
Christopher Fox
et al.		A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse2014
Dr Diana Jurk
Dr Caroline Wilson
Dr Joao Passos
Professor Fiona Oakley
Clara Correia Melo
et al.		Chronic inflammation induces telomere dysfunction and accelerates ageing in mice2014
Dr Graeme O'Boyle
Christopher Fox
Dr Hannah Walden
Dr Joe Willet
Dr Emily Mavin
et al.		Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation2012
Dr Mujdat Zeybel
Dr Timothy Hardy
Frances Wong
Professor John Mathers
Christopher Fox
et al.		Multigenerational epigenetic adaptation of the hepatic wound-healing response2012
Dr Clive Ballard
Christopher Fox
Professor John O'Brien
Professor Alan Thomas
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial2011
12